Ophiomics is growing! We are very happy to have onboard new team members that bring expertise in strategic fields.
Our team will be focused on developing HepatoPredict – A decision tool for Liver Transplantation based on molecular signature, that has recently been awarded funding by the program EIC Accelerator.
Welcome!
Sara
Diana
Maria
André
Filipa
Related Posts
👏💪 It’s out! Our latest study addresses a critical need in gastroenterology: early and accurate identification of Barrett’s Esophagus (BE)
We’re excited to announce that HepatoPredict, our CE-IVD prognostic tool to assess hepatocellular carcinoma (HCC) recurrence in the context of
HepatoDetect Shows Strong Potential for Early HCC Detection HepatoDetect, our AI-driven liquid biopsy platform designed for the early detection of
Now partnering with global institutions and investors to scale innovation where it matters most. Ophiomics is building the world’s first
+351 211 369 829 